Challenging the Status Quo in Early Access – Addressing the Barriers

  • Surfacing the most common “blockers” to access and challenging their validity
  • Exploring who gets to define acceptable risk – and whether patients are meaningfully part of that decision
  • Creating space for more honest, less risk-averse dialogue across stakeholders